ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Pfizer Specialty UK Limited

Pfizer Specialty UK Limited is an active company incorporated on 26 January 2009 with the registered office located in Sandwich, Kent. Pfizer Specialty UK Limited was registered 16 years ago.
Status
Active
Active since 3 years ago
Company No
06801717
Private limited company
Age
16 years
Incorporated 26 January 2009
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 10 January 2025 (7 months ago)
Next confirmation dated 10 January 2026
Due by 24 January 2026 (4 months remaining)
Last change occurred 1 year 7 months ago
Accounts
Submitted
For period 1 Dec30 Nov 2023 (12 months)
Accounts type is Full
Next accounts for period 31 May 2025
Due by 28 February 2026 (5 months remaining)
Contact
Address
Pfizer
Ramsgate Road
Sandwich
Kent
CT13 9NJ
Same address for the past 13 years
Telephone
01304616161
Email
Unreported
Website
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • Solicitor • British • Lives in England • Born in Jan 1974
Director • British • Lives in England • Born in Jul 1968
Pfizer INC
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Pfizer Consumer Healthcare
David Ian Highton and Edwin James Pearson are mutual people.
Active
John Wyeth & Brother Limited
David Ian Highton and Edwin James Pearson are mutual people.
Active
Pharmacia Limited
David Ian Highton and Edwin James Pearson are mutual people.
Active
Pfizer Limited
David Ian Highton and Edwin James Pearson are mutual people.
Active
Seagen U.K. Ltd
David Ian Highton and Edwin James Pearson are mutual people.
Active
Reviral Limited
David Ian Highton and Edwin James Pearson are mutual people.
Active
Pfizer Development Services (UK) Limited
David Ian Highton and Edwin James Pearson are mutual people.
Active
Pfizer R&D UK Limited
David Ian Highton and Edwin James Pearson are mutual people.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2014–2023)
Period Ended
30 Nov 2023
For period 30 Nov30 Nov 2023
Traded for 12 months
Cash in Bank
£42K
Decreased by £420K (-91%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£7.18M
Decreased by £307.34M (-98%)
Total Liabilities
-£164K
Decreased by £383.04M (-100%)
Net Assets
£7.02M
Increased by £75.7M (-110%)
Debt Ratio (%)
2%
Decreased by 119.55% (-98%)
Latest Activity
Accounting Period Extended
1 Month Ago on 24 Jul 2025
Confirmation Submitted
7 Months Ago on 21 Jan 2025
Full Accounts Submitted
1 Year Ago on 8 Aug 2024
Confirmation Submitted
1 Year 7 Months Ago on 17 Jan 2024
Full Accounts Submitted
2 Years Ago on 22 Aug 2023
Confirmation Submitted
2 Years 7 Months Ago on 20 Jan 2023
Dormant Accounts Submitted
3 Years Ago on 10 Jun 2022
Mr Edwin James Pearson Appointed
3 Years Ago on 31 May 2022
Jacqueline Ann Mount Resigned
3 Years Ago on 31 May 2022
Confirmation Submitted
3 Years Ago on 18 Jan 2022
Get Credit Report
Discover Pfizer Specialty UK Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Previous accounting period extended from 30 November 2024 to 31 May 2025
Submitted on 24 Jul 2025
Confirmation statement made on 10 January 2025 with no updates
Submitted on 21 Jan 2025
Full accounts made up to 30 November 2023
Submitted on 8 Aug 2024
Confirmation statement made on 10 January 2024 with updates
Submitted on 17 Jan 2024
Full accounts made up to 30 November 2022
Submitted on 22 Aug 2023
Resolutions
Submitted on 26 Jun 2023
Statement of capital following an allotment of shares on 26 May 2023
Submitted on 8 Jun 2023
Confirmation statement made on 10 January 2023 with no updates
Submitted on 20 Jan 2023
Appointment of Mr Edwin James Pearson as a director on 31 May 2022
Submitted on 7 Jul 2022
Accounts for a dormant company made up to 30 November 2021
Submitted on 10 Jun 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year